MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Localisation of distinct brain networks in premanifest and manifest Huntington’s disease

E. Younger, E. Ellis, J. Joutsa, D. Corp (Burwood, Australia)

Meeting: 2023 International Congress

Abstract Number: 904

Keywords: Chorea (also see specific diagnoses, Huntingtons disease, etc): Pathophysiology

Category: Huntington's Disease

Objective: To map the brain networks underlying Huntington’s Disease (HD), testing whether there are distinct networks involved in premanifest and manifest disease stages.

Background: HD is a genetic, neurodegenerative disorder that involves a myriad of cognitive, psychiatric, and motor impairments. Diagnosis of ‘manifest’ HD is determined by the presence of characteristic motor symptoms, however, gene mutation carriers prior to diagnosis (‘premanifest’ HD) also experience various nonmotor symptoms.  Whilst the etiology of HD is well established, the brain networks involved in these disease stages have not been fully elucidated.

Method: A systematic search was conducted to identify all structural and molecular neuroimaging studies reporting coordinates of significant brain abnormality in HD patients (premanifest or manifest) compared to healthy controls. These coordinates were then extracted and used in coordinate network mapping (CNM) analyses, to identify networks of brain regions that are functionally connected to all the studies’ findings. Three separate CNM analyses were conducted to delineate the networks connected to abnormalities reported in premanifest HD, manifest HD, and all HD (regardless of disease stage).

Results: 23 studies were included, examining premanifest HD (n = 9) and manifest HD (n = 14).  Brain abnormalities reported in all 23/23 studies were functionally connected to focal areas of the left caudate and putamen. CNM analyses also showed premanifest and manifest networks (areas connected to 100% of studies’ findings) localised to distinct portions of the basal ganglia and thalamus with very little overlap, suggesting different areas within these regions may be involved across disease progression. Additionally, the premanifest network encompassed the medial and middle frontal gyri, and cingulate gyrus, whilst the manifest network included the inferior frontal gyri and insula.

Conclusion: We identified brain networks involved in premanifest and manifest HD. Findings demonstrate key involvement of the striatum in HD, however, suggests different portions of these structures may be implicated throughout disease progression. Future work is needed to assess how these networks relate to the specific symptoms experienced by individuals in premanifest and manifest disease stages.

To cite this abstract in AMA style:

E. Younger, E. Ellis, J. Joutsa, D. Corp. Localisation of distinct brain networks in premanifest and manifest Huntington’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/localisation-of-distinct-brain-networks-in-premanifest-and-manifest-huntingtons-disease/. Accessed May 16, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/localisation-of-distinct-brain-networks-in-premanifest-and-manifest-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley